You are here

IMMUNOMEDICS, INC.

Company Information
Address
300 The American Road
Morris Plains, NJ 07950-
United States



Information

UEI: S4NHH3294XM6

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. TC-99M-F(AB)2 Instant Kits for Radioimmunoscintigraphy

    Amount: $50,000.00

    The goal is to develop the optimum clinical agent for radioimmunoscintigraphy. The optimum nuclide is undoubtedly technetium- 99m. Comparing IgG-SH, F(ab')2-SH and Fab'-SH, it is expected that a F(ab' ...

    SBIRPhase I1993Department of Health and Human Services
  2. THE PRODUCTION OF 188 RE-LABELED MONOCLONAL ANTIBODIES

    Amount: $50,000.00

    THE AIM OF THIS PROJECT IS TO ULTIMATELY DEVELOP NOVEL THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER. THE AGENTS ARE BASED ON THE USE OF RADIOLABELED MONOCLONAL ANTIBODY BEARING THE ISOTOPE, RHENIUM- ...

    SBIRPhase I1992Department of Health and Human Services
  3. MONOCLONAL ANTIBODY FOR THERAPY AND DIAGNOSIS

    Amount: $500,000.00

    THE CONTINUING DEVELOPMENT AND EVALUATION OF NEW RADIOCHELATION AGENTS ARE OF UTMOST IMPORTANCE IN TUMOR IMAGING WITH ANTICANCER ANTIBODIES. WHILE DTPA-LABELED IN-111-RADIOIM-MUNOPHARMACEUTICALS ARE W ...

    SBIRPhase II1988Department of Health and Human Services
  4. THE AIM OF THIS PHASE I PROJECT IS TO DEVELOP NOVEL ANTIBODYCONJUGATES FOR USE IN THE RADIOIMMUNODETECTION OF TUMORS.

    Amount: $50,000.00

    THE AIM OF THIS PHASE I PROJECT IS TO DEVELOP NOVEL ANTIBODYCONJUGATES FOR USE IN THE RADIOIMMUNODETECTION OF TUMORS. IN RESPONSE TO THE PROBLEMS ASSOCIATED WITH THE ANTIBODY- DTPA-RADIOMETAL IMAGING ...

    SBIRPhase I1986Department of Health and Human Services
  5. THE OBJECT OF THIS PROJECT IS TO PRODUCE A KIT THAT UTILIZES ANTI-CSAP MONOCLONAL ANTIBODIES (MABS) FOR CLINICAL RADIOIMMUNODETECTION (RAID) OF COLORECTAL AND PANCREATIC CANCERS.

    Amount: $50,000.00

    THE OBJECT OF THIS PROJECT IS TO PRODUCE A KIT THAT UTILIZES ANTI-CSAP MONOCLONAL ANTIBODIES (MABS) FOR CLINICAL RADIOIMMUNODETECTION (RAID) OF COLORECTAL AND PANCREATIC CANCERS. PHASE I WILL BE DEVOT ...

    SBIRPhase I1985Department of Health and Human Services
  6. THIS PROJECT WILL EVALUATE ANTIBODY-MEDIATED, POLYMER-BOUND YTTRIUM-90 AS A CANCER THERAPY AGENT.

    Amount: $50,000.00

    THIS PROJECT WILL EVALUATE ANTIBODY-MEDIATED, POLYMER-BOUND YTTRIUM-90 AS A CANCER THERAPY AGENT. ANTIBODIES WILL BE COUPLED THROUGH ONE COVALENT BOND TO A SMALL POLYLYSINE UNIT. THE LATTER WILL CARRY ...

    SBIRPhase I1985Department of Health and Human Services
  7. THIS PROJECT IS CONCERNED WITH THE DEVELOPMENT OF NONENZYMATIC REAGENTS FOR IMMUNOHISTOCHEMISTRY, WITH EMPHASIS ON ADAPTING THE NEW TECHNOLOGY TO THE EXPANDING FIELD OF IMMUNOHISTOCHEMICAL DIAGNOSIS OF CANCER.

    Amount: $50,000.00

    THIS PROJECT IS CONCERNED WITH THE DEVELOPMENT OF NONENZYMATIC REAGENTS FOR IMMUNOHISTOCHEMISTRY, WITH EMPHASIS ON ADAPTING THE NEW TECHNOLOGY TO THE EXPANDING FIELD OF IMMUNOHISTOCHEMICAL DIAGNOSIS O ...

    SBIRPhase I1985Department of Health and Human Services
  8. MONOCLONAL ANTIBODY FOR THERAPY AND DIAGNOSIS

    Amount: $50,000.00

    N/A

    SBIRPhase I1985Department of Health and Human Services
US Flag An Official Website of the United States Government